presents the Neuronaute, a smart healthcare solution for the diagnosis and monitoring of epilepsy.

communiqué de presse
communiqué de presse
communiqué de presse
CE marking

THEY ARE TALKING ABOUT US !

EPILEPSY IN A FEW FIGURES

Epilepsy accounts for 0.5% of the global burden of disease, a measure combining early loss of life and lifetime with degraded health. Economic impacts are significant in terms of healthcare, premature mortality and loss of productivity.


In the United-­States, 2.2 millions patients are epileptic, of which only 60% receive adequate treatment. In Europe, there are 6 million epileptic patients, of which only 50% receive adequate treatment. A frequent problem is improper or incomplete diagnosis.


Recorded seizures are necessary to fine tune a diagnosis. Currently, the recording procedure requires hospitalization in a specially equipped hospital unit. Recording usually lasts from 1 to 48 hours, but this duration is not always sufficient to record a seizure.


It’s the approximate waiting time for a pre-surgical diagnosis in some developed countries. Cur-rent systems are expensive, scar-cely available and require complete immobilization of the hospi-talized patient, which can be strenuous, particularly for children.


HOW DOES IT WORK ?

The Internet of Things dedicated to healthcare

Smart clothing equipped with biometric sensors that records physiological characteristics.

An innovative smartphone app that processes and analyses data originating from the smart clothing.

A Cloud system that gathers data allowing in depth analysis and information sharing.

REVOLUTIONIZES THE PATIENT’S LIFE

HOME MONITORING

The Neuronaute tracks physiological characteristics of the epileptic patient in real time. As soon as there is a sign of seizure identified, a warning can be triggered and the smartphone will be able to broadcast to listeners and care takers the proper procedure to follow.

See their testimony :

Testimony 1

"Isabelle has a 4 year old son. Her son has already suffered from two seizures. She has recently learned of the existence of SUDEP (Sudden Unexpected Death in EPilepsy) and she has been extremely worried since. She would be reassured to know that her son is monitored and that she would be warned in case of seizure."

Testimony 2

"Anya had her first seizure at the age of 8 years old and a second one at the age of 18 years old. She didn’t pay much attention to it then. When she became a mom at the age of 24, every changed. She suffered from a major seizure while carrying her two month old son. Nowadays, Anya would like it if her close ones would know what to do if she has a seizure."

Testimony 3

"David is a policeman in an average size town. Not so long ago, his 6 year old daugh-ter was spending the week-end at her grandparents when she suddenly lost consci-ousness and fell to the ground. After a trip to the emergency room and hospitaliza-tion, his daughter was diagnosed. Now David would like a monitoring system in order to reassure teachers and grandparents when they are taking care of his daughter."

REVOLUTIONIZES THE DIAGNOSIS

ADJUSTING A MEDICAL TREATMENT

Data shared through the cloud can be accessed at any time by the doctor in charge of the patient. The doctor can use the data for an optimized diagnosis and can view the response to a medical treatment and adjust it accordingly in real time.

REVOLUTIONIZES MEDICAL RESEARCH

To know more about us, let's watch our video on Youtube

A LITTLE HELLO

CONTACT US

Merci de remplir les champs notés x

Interested on getting project updates
follow-us on Facebook, Twitter and Google+

LOCATE US

BioSerenity
ICM - iPEPS
47 Boulevard Hôpital
75013 Paris | France

THE TEAM

BioSerenity is composed of a diverse group of talented individuals (doctors, engineers, designers, …). All dynamic, friendly, motivated and very skilled. If this description also applies to you and you have skills linked to our solutions, (Cloud, Mobile app, Signal processing, for instance) don’t hesitate to contact us.


AWARD

NOS PARTENAIRES !